These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

928 related articles for article (PubMed ID: 6996812)

  • 1. DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-methylpyrimidine).
    Hill BT; Price LA
    Cancer Treat Rev; 1980 Jun; 7(2):95-112. PubMed ID: 6996812
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of diamino-dichlorophenyl-methylpyrimidine (DDMP) with folinic acid (CF) protection and rescue.
    Alberto P; Brugarolas A; Hansen HH; Cavalli F; Klepp O; Renard J
    Eur J Cancer (1965); 1980 Sep; 16(9):1243-9. PubMed ID: 6971756
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies with a 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP)-resistant L1210 leukemia cell line without cross-resistance to methotrexate.
    Browman GP; Gorka C; Mehta C; Lazarus H; Abelson HT
    Biochem Pharmacol; 1980 Aug; 29(16):2241-5. PubMed ID: 7426028
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II clinical trial of DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine) and folinic acid (CF) in solid tumors.
    de Jager R; Brugarolas A; Hansen M
    Cancer Chemother Pharmacol; 1981; 6(1):81-4. PubMed ID: 6974059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I clinical trial and pharmacology of 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (metoprine) (DDMP) and folinic acid (CF).
    de Jager R; Dupont D; Rodzynek JJ; Dorlet C; Lagrange G
    Cancer Chemother Pharmacol; 1981; 6(1):75-80. PubMed ID: 6974058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallographic studies of the antineoplastic antifolate 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP) ethanesulfonate salt.
    Cody V
    Cancer Biochem Biophys; 1983; 6(3):173-7. PubMed ID: 6850552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of DDMP (2, 4-diamino-5-3', 4'-dichlorophenyl-6-methylpyrimidine) on brain gliomas--a phase II study. E.O.R.T.C. Brain Tumor Group.
    Eur J Cancer (1965); 1980 Dec; 16(12):1639-40. PubMed ID: 7227437
    [No Abstract]   [Full Text] [Related]  

  • 8. Lethal and kinetic effects of DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine).
    Hill BT
    Eur J Cancer (1965); 1980 Jan; 16(1):147-57. PubMed ID: 6987066
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical impact of screening and other experimental tumor studies.
    Johnson RK; Goldin A
    Cancer Treat Rev; 1975 Mar; 2(1):1-31. PubMed ID: 1102083
    [No Abstract]   [Full Text] [Related]  

  • 10. Disposition of mitoxantrone in patients.
    Alberts DS; Peng YM; Leigh S; Davis TP; Woodward DL
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():23-7. PubMed ID: 6661732
    [No Abstract]   [Full Text] [Related]  

  • 11. Initial clinical experience with a simultaneous combination of 2,4-diamino-5(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP) with folinic acid.
    Alberto P; Peytremann R; Medenica R; Beretta-Piccoli M
    Cancer Chemother Pharmacol; 1978; 1(2):101-5. PubMed ID: 373910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative high-pressure liquid chromatographic procedure for the determination of plasma and tissue levels of 2,4-diamino-5-(3,4-dichlorophenyl)-6-methylpyrimidine (metoprine) and its application to the measurement of brain capillary permeability coefficients.
    Levin EM; Meyer RB; Levin VA
    J Chromatogr; 1978 Aug; 156(1):181-7. PubMed ID: 689956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An enzyme inhibition assay for 2,4-diamino-5-(3'4'-dichlorophenyl)-6-methylpyrimidine (DDMP,NSC 19494).
    Calvert AH; Cridland JS; Harrap KR
    J Clin Pathol; 1977 Dec; 30(12):1154-7. PubMed ID: 604362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin (Mutamycin).
    Med Lett Drugs Ther; 1975 Jul; 17(15):62-3. PubMed ID: 50555
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of antitumor activity of 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine and Baker's antifol (triazinate) with carboxypeptidase G1.
    Kalghatgi KK; Moroson BA; Horváth C; Bertino JR
    Cancer Res; 1979 Sep; 39(9):3441-5. PubMed ID: 476673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancer.
    Chahinian AP; Mandel EM; Holland JF; Jaffrey IS; Teirstein AS
    Cancer; 1979 May; 43(5):1590-7. PubMed ID: 221093
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of an intermittent schedule of mitolactol in advanced non-small cell lung cancer.
    Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK; Coles DT
    Cancer Treat Rep; 1981; 65(11-12):1099-1101. PubMed ID: 6271397
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II trial of 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
    Joss RA; Obrecht JP; Alberto P; Siegenthaler P; VanHelvoirt A; Cavalli F
    Cancer Treat Rep; 1984 Mar; 68(3):563-4. PubMed ID: 6322990
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the antitumor activity and toxicity of 2,4-diamino-5-(1-adamantyl)-6-methylpyrimidine and 2,4-diamino-5-(1-adamantyl)-6-ethylpyrimidine.
    Zakrzewski SF; Dave C; Rosen F
    J Natl Cancer Inst; 1978 May; 60(5):1029-33. PubMed ID: 580441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isolation of a polymer from Chamaenerium angustifolium and study of its antineoplastic action].
    Pukhal'skaia ECh; Petrova MF; Kibal'chich PN; Alieva TA; Denisova SI
    Antibiotiki; 1970 Sep; 15(9):782-5. PubMed ID: 5536919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 47.